CROs/Service Providers

Vention Medical adds new facility in Ireland

Wednesday, August 31, 2016

Vention Medical has opened an additional facility in Ireland to more closely collaborate with customers in the region and accelerate their development initiatives. The new facility will provide medical device design and development services and house Vention’s team of dedicated development professionals.

[Read More]

Metrion Biosciences joins human pain research consortium

Monday, August 29, 2016

Metrion Biosciences, a specialist ion-channel and drug discovery CRO, has entered into an agreement with a network of partners to evaluate the use of primary human dorsal root ganglion (hDRG) neurons in pain research. This Consortium comprises the University of Glasgow, the University of St. Andrews, NHS Greater Glasgow & Clyde (NHS-GGC), Metrion Biosciences, the Grünenthal Group in Germany, and the U.K. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), with vital support and facilitation by NHS Blood & Transplant (Scotland). 

[Read More]

Biomedical Systems, Foundry Health partner for real-time data access

Tuesday, August 23, 2016

Biomedical Systems, a 40-year-old, family-owned, clinical trial provider to pharmaceutical, medical device, biotech and CROs, has announced a new partnership with digital health company Foundry Health of Chicago. The two companies will collaborate on the development of a proprietary cloud-based data management system that will allow sponsors immediate access to clinical trial data in real time.

[Read More]

Frenova Renal Research expands in the U.S.

Tuesday, August 23, 2016

Frenova Renal Research, a drug and medical device contract clinical development services provider dedicated to renal research, announced its opening of a new office location in downtown Durham, North Carolina, and the expansion of its U.S. field-based staff in New York, Illinois, North Carolina, Florida and Louisiana.

[Read More]